GlassScriptPrepare for your visit
Christopher Wesley Mangieri
Surgery · Apo, AA · NPI 1316234685
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$272.78
in general payments reported to CMS, 2019-2025 · $273 in 2025
The $273 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Who reported paying
General payments only, top 4 by amount.
- Medtronic, INC. $116.92
- Davol INC. $99.30
- Tela Bio, INC. $30.38
- Ethicon US, LLC $26.18
Drugs and devices associated with these payments
Transorb Arista Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) Echelon Flex
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Christopher Mangieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/286910/christopher-wesley-mangieri